Showing results (441-450 of 739) with videos related to
Sort By:
Pageof 74
The Journal of Infectious Diseases|September 24, 2008
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trialWendy A Keitel, James D Campbell, John J Treanor, et al.Vaccine|October 24, 2017
The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young childrenEmmanuel B Walter, Christoph P Hornik, Lisa Grohskopf, et al.Vaccine|March 7, 2015
Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervalsKate Russell, Eileen F Dunne, Alex R Kemper, et al.Journal of Drug Assessment|July 24, 2018
Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)Utkarsh H Acharya, Anna B Halpern, Qian Vicky Wu, et al.The Pediatric Infectious Disease Journal|November 15, 2019
A Pharmacoepidemiologic Study of the Safety and Effectiveness of Clindamycin in InfantsRachel G Greenberg, Huali Wu, Anil Maharaj, et al.Journal of Cancer Research and Clinical Oncology|December 29, 2011
Mutational activation of FGFR3: no involvement in the development of renal cell carcinomaC G Stoehr, R Stoehr, A Hartmann, et al.International Immunology|March 1, 1997
Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexesJ B Walter, C Brander, M Mammen, et al.European Cells & Materials|January 19, 2021
Non-viral reprogramming of human nucleus pulposus cells with FOXF1 via extracellular vesicle delivery: an in vitro and in vivo studyS Tang, A Salazar-Puerta, J Richards, et al.World Journal of Urology|February 22, 2012
Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy coresB Walter, T Weiss, F Hofstädter, et al.Haematologica|October 22, 2013
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II studyRoland B Walter, Bruno C Medeiros, Kelda M Gardner, et al.Pageof 74